Following the announcement of receiving the CE mark in early 2018, ab medica has now reported the first-in man usage of its blueflow Venous Stent. The company signed an exclusive distribution agreement for the blueflow Venous Stent with plus medica GmbH & Co. KG at the beginning of the year.
The blueflow Venous Stent, developed and manufactured in Germany, is a two Nitinol wire braided stent. It comes in different diameters and lengths to fulfill requirements in treating chronic venous outflow obstructions. The first procedure was recently performed by Michael Lichtenberg, head of Interventional Angiology and German Venous Center at Klinikum Arnsberg, Arnsberg, Germany.
“We are pleased to be the first worldwide centre to treat patients with venous outflow obstruction using the blueflow Venous Stent,” Lichtenberg says. “The very first patient we treated had a chronic total occlusion of the left common and external iliac vein. The blueflow Venous Stent restored outflow. The addition of a dedicated venous stent which especially increases my treatment options below the ligament can help patients alleviate symptoms and increase their quality of life.”
Georg Landsberg, managing director ab medica Germany, states that the “high flexibility [of the stent] gives the physician more treatment options below the inguinal ligament”.
Additional dedicated venous centers in Europe are lined up to use the stent in treatment of chronic venous outflow obstructions, in particular below the inguinal ligament.